Combination therapy with PD-1 blockade and radiofrequency ablation for recurrent hepatocellular carcinoma: a propensity score matching analysis

Combination therapy with PD-1 blockade and radiofrequency ablation for recurrent hepatocellular carcinoma: a propensity score matching analysis

Background This study aimed to evaluate whether combined therapy with PD-1 blockade (anti-PD-1) and radiofrequency ablation (RFA) is superior to RFA monotherapy for recurrent hepatocellular carcinoma (HCC). Methods A total of 127 patients who underwent anti-PD-1 plus RFA treatment (n = 41) or RFA al...

Full description

Bibliographic Details
Main Authors: Xiaofei Wang, Guo Liu, Shu Chen, Huaqiang Bi, Feng Xia, Kai Feng, Kuansheng Ma, Bing Ni
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:International Journal of Hyperthermia
Subjects:
hepatocellular carcinoma
radiofrequency ablation
pd-1 blockade
t cell
immune responses
Online Access:http://dx.doi.org/10.1080/02656736.2021.1991011

Internet

http://dx.doi.org/10.1080/02656736.2021.1991011

Similar Items